Cesarean Section
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Cesarean Section is a highly competitive landscape with 165 programs across 45 companies. The most active players are Edison Pharmaceuticals Inc, Javelin Pharmaceuticals, Milestone Pharmaceuticals Inc.. 62 therapies are approved with 22 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Analysis
Modality Breakdown
100%
Small molecule
222 of 223 classified programs — the dominant modality here.
Small molecule leads; the ring shows all 223 classified programs, each share of the total. Modality classified for 100% of 231 pipeline programs.
Analysis
Trial Status
304
clinical trials
Clinical Trials
Trial Activity
304 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)